EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrating Biomarker‐Based Fatty Liver Indices Into Multidisciplinary Treatment Pathways for Digestive Tumors

Xudong Song, Jingjing Dai, Guoquan Tao

iLABMED · 2026-06 · 4 (2) · 130-131

DOI: 10.1002/ila2.70056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift iLABMED, online erschienen am 30.05.2026. Verfasst von Xudong Song und 2 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Song, X., Dai, J., & Tao, G. (2026). Integrating Biomarker‐Based Fatty Liver Indices Into Multidisciplinary Treatment Pathways for Digestive Tumors. iLABMED, 4(2), 130-131. https://doi.org/10.1002/ila2.70056

Vancouver

Song X, Dai J, Tao G. Integrating Biomarker‐Based Fatty Liver Indices Into Multidisciplinary Treatment Pathways for Digestive Tumors. iLABMED. 2026;4(2):130-131. doi:10.1002/ila2.70056

BibTeX
@article{Song2026,
  author = {Song, Xudong and Dai, Jingjing and Tao, Guoquan},
  title = {Integrating Biomarker‐Based Fatty Liver Indices Into Multidisciplinary Treatment Pathways for Digestive Tumors},
  journal = {iLABMED},
  year = {2026},
  volume = {4},
  number = {2},
  pages = {130--131},
  doi = {10.1002/ila2.70056}
}
Kostenlos starten →